Issuer Delisting; Notice of Application To Withdraw From Listing and Registration on the American Stock Exchange LLC (ALARIS Medical Systems, Inc., Common Stock, $.01 Par Value) File No. 1-10207

Download PDF
Federal RegisterSep 16, 2003
68 Fed. Reg. 54249 (Sep. 16, 2003)
September 10, 2003.

ALARIS Medical Systems, Inc., a Delaware corporation (“Issuer”), has filed an application with the Securities and Exchange Commission (“Commission”), pursuant to section 12(d) of the Securities Exchange Act of 1934 (“Act”) and rule 12d2-2(d) thereunder, to withdraw its Common Stock, $.01 par value (“Security”), from listing and registration on the American Stock Exchange LLC (“Amex” or “Exchange”).

15 U.S.C. 78 l (d).

The Issuer states that it wishes to withdraw its Security from listing and registration on the Amex and to list its Security on the New York Stock Exchange, Inc. (“NYSE”). The Issuer believes that the global recognition of the NYSE will be beneficial to the Issuer and its shareholders. The Issuer states that it intends to list the Security on the NYSE on September 25, 2003.

The Issuer stated in its application that it has met the requirements of Amex Rule 18 by complying with all applicable laws in the State of Delaware, in which it is incorporated, and with the Amex's rules governing an issuer's voluntary withdrawal of a security from listing and registration.

The Issuer's application relates solely to the withdrawal of the Securities from listing on the Amex and from registration under section 12(b) of the Act shall not affect its obligation to be registered under section 12(g) of the Act.

15 U.S.C. 78 l (b).

15 U.S.C. 78 l (g).

Any interested person may, on or before October 6, 2003, submit by letter to the Secretary of the Securities and Exchange Commission, 450 Fifth Street, NW., Washington, DC 20549-0609, facts bearing upon whether the application has been made in accordance with the rules of the Amex and what terms, if any, should be imposed by the Commission for the protection of investors. The Commission, based on the information submitted to it, will issue an order granting the application after the date mentioned above, unless the Commission determines to order a hearing on the matter.

For the Commission, by the Division of Market Regulation, pursuant to delegated authority.

Jonathan G. Katz,

Secretary.

[FR Doc. 03-23532 Filed 9-15-03; 8:45 am]

BILLING CODE 8010-01-M